The percentage tumor weight reduction was also significantly lower for the SAM+anti-PD-1 group (71%) relative to control (p < 0.0001) and SAM (39%, p < 0.05) (Supplementary Figure 2). The gene discussed is PDCD1; the disease is neoplasm.